New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 24, 2014
04:55 EDTEW, EW, EW, EW, EW, QDEL, QDEL, QDEL, QDEL, QDEL, SQNM, SQNM, SQNM, SQNM, SQNM, TNDM, TNDM, TNDM, TNDM, TNDM, VOLC, VOLC, VOLC, VOLC, VOLC, ATEC, ATEC, ATEC, ATEC, ATEC, CFN, CFN, CFN, CFN, CFN, ICUI, ICUI, ICUI, ICUI, ICUI, IART, IART, IART, IART, IART, ELGX, ELGX, ELGX, ELGX, ELGX, NUVA, NUVA, NUVA, NUVA, NUVAPiper Jaffray to hold a bus tour
7th Annual SoCal Medtech & Diagnostics Bus Tour to travel throughout San Diego on August 25-28.
News For EW;ELGX;IART;ICUI;CFN;ATEC;VOLC;TNDM;SQNM;QDEL;NUVA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 26, 2014
07:11 EDTCFNBecton Dickinson upgraded to Overweight from Neutral at JPMorgan
Subscribe for More Information
November 21, 2014
08:36 EDTTNDMTandem Diabetes announces partnership with Tidepool
Tandem Diabetes Care announced a partnership with Tidepool, a non-profit dedicated to improving diabetes therapy management by offering an open source software platform that increases diabetes data accessibility. This partnership will enable users of the Tidepool Platform, which is currently under development, to download and access data from their t:slim Insulin Pump.
08:15 EDTNUVANuVasive price target raised to $48 from $44 at Summer Street
Subscribe for More Information
07:16 EDTELGXEndologix trial results 'highly encouraging,' says Stifel
Subscribe for More Information
November 20, 2014
09:07 EDTCFNBecton Dickinson, CareFusion announce expiration of HSR act waiting period
Becton, Dickinson (BDX) and CareFusion (CFN) announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, in connection with BD's proposed acquisition of CareFusion expired on November 19. The expiration of the HSR Act waiting period satisfies a condition to the proposed acquisition. The proposed acquisition remains subject to certain other conditions and approvals.
07:13 EDTELGXCanaccord to hold a forum
Subscribe for More Information
November 18, 2014
11:00 EDTELGXEndologix to host investor meeting
Subscribe for More Information
07:11 EDTELGXEndologix completes patient enrollment in Nellix EVAS FORWARD-IDE clinical trial
Endologix announced that it has completed patient enrollment in the EVAS FORWARD-IDE clinical trial, the company's U.S. pivotal clinical trial designed to evaluate the safety and effectiveness of the Nellix EndoVascular Aneurysm Sealing System for the endovascular repair of infrarenal abdominal aortic aneurysms, or AAA. Primary endpoint analysis results at one-year and beyond will be used to support the company's premarket approval, or PMA, application to the FDA for the Nellix EVAS System. The EVAS FORWARD-IDE clinical trial enrolled 179 patients at 29 centers in the U.S. and Europe. Enrollment under an extended investigation phase is anticipated to begin shortly and will continue during the pivotal trial follow-up period and PMA preparation/review process. Based on current assumptions and timelines, the company anticipates FDA approval of the Nellix System in the U.S. before the end of 2016.
November 17, 2014
10:02 EDTNUVA, VOLCOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: CyrusOne (CONE) upgraded to Buy from Hold at Stifel... MGIC Investment (MTG) upgraded to Conviction Buy from Buy at Goldman... NuVasive (NUVA) upgraded to Outperform from Market Perform at Wells Fargo... Phillips 66 (PSX) upgraded to Outperform from Neutral at Credit Suisse... Pinnacle Foods (PF) upgraded to Buy from Hold at Deutsche Bank... Rayonier (RYN) upgraded to Outperform from Sector Perform at RBC Capital.. Thoratec (THOR) upgraded to Outperform from Market Perform at Wells Fargo... Volcano (VOLC) upgraded to Outperform from Neutral at Credit Suisse... Progressive Waste (BIN) upgraded to Neutral from Underperform at Macquarie... Clean Harbors (CLH) upgraded to Outperform from Neutral at Wedbush... McGraw Hill Financial (MHFI) upgraded to Buy from Hold at Benchmark Co... Chesapeake (CHK) upgraded to Outperform from Market Perform at Bernstein... American Science & Engineering (ASEI) upgraded to Fair Value from Sell at CRT Capital... Sony (SNE) upgraded to Overweight from Equal Weight at Morgan Stanley.
05:49 EDTVOLCVolcano upgraded to Outperform from Neutral at Credit Suisse
Subscribe for More Information
05:39 EDTNUVANuVasive upgraded to Outperform from Market Perform at Wells Fargo
Wells Fargo upgraded NuVasive to Outperform after attending last week's North American Spine Society annual meeting. Wells believes the worldwide spine market continues to improve and that NuVasive is well positioned to capitalize on the momentum. The firm raised its price target range for shares to $50-$52 from $43-$44.
November 14, 2014
08:59 EDTNUVANuVasive price target raised to $51 from $49 at Canaccord
Subscribe for More Information
November 13, 2014
08:39 EDTIARTIntegra LifeSciences announces FDA clearance for spinal fusion procedures
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use